Primary medical therapy for acromegaly: An open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4554-4563

  Bevan, J S ^a   Atkin, S L ^a   Atkinson, A B ^a   Bouloux, P M ^a   Hanna, F ^a   Harris, P E ^a   James, R A ^a   McConnell, M ^a   Roberts, G A ^a   Scanlon, M F ^a   Stewart, P M ^a   Teasdale, E ^a   Turner, H E ^a   Wass, J A H ^a   Wardlaw, J M ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN ANALOG;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; EDEMA; ERYTHEMA; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADENOMA; IMAGE ANALYSIS; INJECTION PAIN; MALE; MICROADENOMA; MULTICENTER STUDY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR VOLUME; UNITED KINGDOM;

ACROMEGALY; ADENOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; DELAYED-ACTION PREPARATIONS; FEMALE; HUMAN; HUMAN GROWTH HORMONE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; INSULIN-LIKE GROWTH FACTOR I; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGE; OCTREOTIDE; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036775244     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2001-012012     Document Type: Article

References (22)

1. Stewart PM 2000 Current therapy for acromegaly. Trends Endocrinol Metab 11:128-132
2. Swearingen B, Barker FG, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT 1998 Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426
3. Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CBT, Wass JAH 1999 Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) 50:561-567
4. Abe T, Ludecke DK 2001 Effects of pre-operative octreotide treatment on different subtypes of 90 growth hormone secreting pituitary adenomas and outcome in one surgical centre. Eur J Endocrinol 145:137-145
5. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM, Wass JA 1996 Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol (Oxf) 45:407-413
6. Colao A, Ferone D, Cappabianca P, del Basso De Caro ML, Marzullo P, Monticelli A, Alfieri A, Merola B, Cali A, de Divitiis E, Lombardi G 1997 Effect of octreotide pretreatment on surgical outcome in acromegaly. J Clin Endocrinol Metab 82:3308-3314
7. Clayton RN 1999 How many surgeons to operate on acromegalic patients? Clin Endocrinol (Oxf) 50:557-559
8. Jaffe CA 1999 Reevaluation of conventional pituitary irradiation in the therapy of acromegaly. Pituitary 2:55-62
9. Barkan A, Lloyd RV, Chandler WF, Hatfield MK, Gebarski SS, Kelch RP, Beitins IZ 1988 Preoperative treatment of acromegaly with long-acting somatostatin analog SMS 201-995: Shrinkage of invasive pituitary macroadenomas and improved surgical remission rate. J Clin Endocrinol Metab 67:1040-1048
10. Sassolas G, Harris AG, James-Didier A, and the French SMS 201-995 acromegaly study group. 1990 Long-term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. J Clin Endocrinol Metab 71:391-397
11. Vance ML, Harris AG 1991 Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the international multi-center acromegalic study group. Arch Intern Med 151:1573-1578
12. James RA, Chatterjee S, White MC, Hall K, Moller N, Kendall-Taylor P 1989 Continuous infusion of octreotide in acromegaly. Lancet 2:1083-1087
13. Lundin P, Engstrom BE, Karlsson FA, Burman P 1997 Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: Evaluation with serial MR. Am J Neuroradiol 18:765-772
14. Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL 1998 Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab 83:3034-3040
15. Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G 2001 Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 86:2779-2786
16. Whalley HC, Wardlaw JM 2001 Accuracy and reproducibility of simple cross-sectional linear and area measurements of brain structures and their comparison with volume measurements. Neuroradiology 43:263-271
17. Bevan JS, Webster J, Burke CW, Scanlon MF 1992 Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 13:220-240
18. Gillis JC, Noble S, Goa KL 1997 Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly. Drugs 53:681-699
19. Orme SM, McNally RJ, Cartwright RA, Belchetz PE 1998 Mortality and cancer incidence in acromegaly: A retrospective cohort study. United Kingdom acromegaly study group. J Clin Endocrinol Metab 83:2730-2734
20. Dowling RH, Hussaini SH, Murphy GM, Besser GM, Wass JAH 1992 Gallstones during octreotide therapy. Metabolism 41:22-33
21. Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ 2000 Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 342:1171-1177
22. Abs R, Verhelst J, Maiter D, van Acker K, Nobels F, Coolens JL, Mahler C, Beckers A 1998 Cabergoline in the treatment of acromegaly: A study in 64 patients. J Clin Endocrinol Metab 83:374-378